Cargando…

Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits

Proton pump inhibitors (PPIs) represent a milestone in the treatment of acid-related diseases, and are the mainstay in preventing upper gastrointestinal bleeding in high-risk patients treated with nonsteroidal anti-inflammatory drugs (NSAIDs) or low-dose aspirin. However, this beneficial effect does...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lué, Alberto, Lanas, Angel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192259/ https://www.ncbi.nlm.nih.gov/pubmed/28082800 http://dx.doi.org/10.3748/wjg.v22.i48.10477

Ejemplares similares

Effect of Proton Pump Inhibitors on Risks of Upper and Lower Gastrointestinal Bleeding among Users of Low-Dose Aspirin: A Population-Based Observational Study
por: García Rodríguez, Luis A., et al.
Publicado: (2020)

A Study of Proton Pump Inhibitors and Other Risk Factors in Warfarin-Associated Gastrointestinal Bleeding
por: Tang, Jevon, et al.
Publicado: (2021)

Risk of upper gastrointestinal bleeding in patients on oral anticoagulant and proton pump inhibitor co-therapy
por: Lee, Hyun-Jung, et al.
Publicado: (2021)

Divergent trends of hospitalizations for upper and lower gastrointestinal bleeding based on population prescriptions of aspirin, proton pump inhibitors and Helicobacter pylori eradication therapy: Trends of upper and lower gastrointestinal bleeding
por: Guo, Chuan‐Guo, et al.
Publicado: (2021)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Nonvitamin K oral anticoagulants with proton pump inhibitor cotherapy ameliorated the risk of upper gastrointestinal bleeding
por: Chaiyana, Parata, et al.
Publicado: (2023)

Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds
por: Komen, Joris, et al.
Publicado: (2022)

Risk of Pyogenic Liver Abscess in Proton Pump Inhibitor Users: New Inventory of Proton Pump Inhibitor Induced Complications?
por: Bang, Ki Bae
Publicado: (2021)

Prognosis of concomitant users of clopidogrel and proton-pump inhibitors in a high-risk population for upper gastrointestinal bleeding
por: Wang, Qing, et al.
Publicado: (2014)

Effects of postoperative use of proton pump inhibitors on gastrointestinal bleeding after endoscopic variceal treatment during hospitalization
por: Zhang, Yi-Yan, et al.
Publicado: (2023)

Proton pump inhibitors: A balanced view
por: Ramakrishna, B.S.
Publicado: (2015)

The Complex Interaction between Proton Pump Inhibitors and Cancer Treatment
por: Chen, Hao, et al.
Publicado: (2023)

Balancing gastrointestinal benefit–risk in individuals who are prescribed NSAIDs for arthritis
por: Bijlsma, Johannes W. J.
Publicado: (2010)

Proton Pump Inhibitors Display Antitumor Effects in Barrett's Adenocarcinoma Cells
por: Chueca, Eduardo, et al.
Publicado: (2016)

Proton Pump Inhibitor-associated Mucosal Change
por: Kato, Mototsugu, et al.
Publicado: (2017)

Proton pump inhibitors in the COVID-19 pandemic()
por: Sebastián Domingo, Juan J.
Publicado: (2021)

Reduction of major gastrointestinal bleeding risk with proton pump inhibitor therapy in patients with atrial fibrillation receiving direct oral anticoagulant
por: Lee, S R, et al.
Publicado: (2023)

Intermittent Proton Pump Inhibitor Therapy in Low-Risk Non-Variceal Upper Gastrointestinal Bleeding May Be Significantly Cost-Saving
por: Lei, Yang, et al.
Publicado: (2023)

Daily Usage of Proton Pump Inhibitors May Reduce the Severity of Critical Upper Gastrointestinal Bleeding in Elderly Patients
por: Matsuda, Hidetaka, et al.
Publicado: (2020)

Lower Gastrointestinal Bleeding And Risk of Gastrointestinal Cancer
por: Viborg, Søren, et al.
Publicado: (2016)

Incidence of cardiovascular events and gastrointestinal bleeding in patients receiving clopidogrel with and without proton pump inhibitors: an updated meta-analysis
por: Cardoso, Rhanderson N, et al.
Publicado: (2015)

High-Dose Proton Pump Inhibitors Are Superior to Standard-Dose Proton Pump Inhibitors in High-Risk Patients With Bleeding Ulcers and High-Risk Stigmata After Endoscopic Hemostasis
por: Zhu, Zhenhua, et al.
Publicado: (2021)

New Trends and Advances in Non-Variceal Gastrointestinal Bleeding—Series II
por: Cañamares-Orbís, Pablo, et al.
Publicado: (2021)

Can proton pump inhibitors cause intestinal inflammation in children?
por: Kang, Ben
Publicado: (2019)

H(2) antagonists, proton pump inhibitors and COVID-19
por: Hirota, Kazuyoshi
Publicado: (2022)

Influence of Proton-Pump Inhibitors on the Luminal Microbiota in the Gastrointestinal Tract
por: Tsuda, Ayumi, et al.
Publicado: (2015)

Are proton pump inhibitors a double-edged sword in the treatment of Helicobacter pylori infection?
por: Ge, Ruiguang
Publicado: (2012)

Low-dose aspirin and risk of upper/lower gastrointestinal bleeding by bleed severity: a cohort study with nested case-control analysis using primary care electronic health records from the United Kingdom
por: García Rodríguez, Luis A., et al.
Publicado: (2019)

Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits
por: Gwee, Kok Ann, et al.
Publicado: (2018)

High or Nonhigh Doses of Proton Pump Inhibitors for Patients with Peptic Ulcer Bleeding?
por: Hsieh, Yu-Hsi, et al.
Publicado: (2013)

Cirrhotic patients on proton pump inhibitors are at a twofold risk of spontaneous bacterial peritonitis independently of gastrointestinal bleeding: a population-based retrospective study
por: Boustany, Antoine, et al.
Publicado: (2023)

Effects of high-dose versus low-dose proton pump inhibitors for treatment of gastrointestinal ulcer bleeding: a meta-analysis of randomized controlled trials
por: Zhu, Wei, et al.
Publicado: (2022)

Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease
por: Shi, Yi-Chao, et al.
Publicado: (2019)

Balancing risk and benefit during coronavirus
por: Sehn, Laurie H.
Publicado: (2020)

Balancing the gastrointestinal benefits and risks of nonselective NSAIDs
por: Peura, David A, et al.
Publicado: (2005)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
por: Laredo, Viviana, et al.
Publicado: (2020)

Proton Pump Inhibitor-Responsive Esophageal Eosinophilia: Controversies and Its Clinical Implications
por: Shin, Cheol Min, et al.
Publicado: (2016)

Failure of optimized dual proton pump inhibitor amoxicillin therapy: What now?
por: Graham, David Y., et al.
Publicado: (2017)

Can Nocturnal Acid-breakthrough Be Reduced by Long-acting Proton Pump Inhibitors?
por: Jeon, Hye Kyung, et al.
Publicado: (2017)

Balancing Between Ischemic and Bleeding Risk in PCI Patients With ‘Bi-Risk’
por: Park, Mahn-Won
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ik3klctonppimo8rq5rnhjedn6